Telix Pharmaceuticals focuses on the development of novel radiopharmaceuticals and nuclear medicine compounds for the treatment of cancer. I have been a part of several commercial projects with Telix Pharmaceuticals towards the development of novel prostate cancer treatments. Due to the contract nature of these projects, no more information other than the titles (see Outputs tab) of the projects and those involved can be disclosed.
Dr. Zachary H. Houston
Postdoctoral Fellow at The University of Queensland
Contract work: Telix Pharmaceuticals
Contracts were negotiated between Clarity Pharmaceuticals and the Centre for Advanced Imaging at the University of Queensland. I was involved with the radiolabelling, purification of the radiolabelled compounds, imaging, animal handling, and treatment monitoring. All people involved in this project (other than myself) and their roles are listed below (Affiliations denoted in superscripts).
- Kristofer J. Thurecht1,2,3,4 – Project design and management
- Nicholas L. Fletcher1,2,3 – Radiolabelling and purification.
Affiliations
- Centre for Advanced Imaging, The University of Queensland, St Lucia, QLD 4072, Australia.
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD 4072, Australia.
- ARC Centre of Excellence in Convergent BioNano Science and Technology, The University of Queensland, St Lucia, QLD 4072, Australia
- ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, St Lucia, QLD 4072, Australia